Houlihan Lokey, Inc., an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory. The Corporate Finance segment offers general financial advisory services; and advises public and private institutions on buy-side and sell-side transactions, leveraged loans, private mezzanine debt, high-yield debt, initial public offerings, follow-ons, convertibles, equity private placements, private equity, and liability management transactions, as well as advise financial sponsors on various transactions. The Financial Restructuring segment advises debtors, creditors, and other parties-in-interest related to recapitalization/deleveraging transactions. It also provides a range of advisory services, including structuring, negotiation, and confirmation of plans of reorganization; structuring and analysis of exchange offers; corporate viability assessment; dispute resolution and expert testimony; and procuring debtor-in-possession financing. The Financial and Valuation Advisory segment offers valuations of various assets, such as companies, illiquid debt and equity securities, and intellectual property. It also provides fairness opinions in connection with M&A and other transactions, and solvency opinions in connection with corporate spin-offs and dividend recapitalizations; and other types of financial opinions. In addition, this segment offers dispute resolution services. It serves corporations, institutions, and governments. The company was incorporated in 1972 and is headquartered in Los Angeles, California with offices in the United States, Europe, the Middle East, and the Asia-Pacific region.

Houlihan Lokey, Inc.

Statement of Changes in Beneficial Ownership

Insider	Title	Transaction Type	Shares Traded	% of Shares Traded	% Chg. in Shares	End of Filing Shares	Price	Transaction Value	Filing Date	Transaction Date
Christopher M. Crain	MD, General Counsel & Secretary, Co-Owner Show All	Derivative Exercise and Sale (Sale)	-40	-0.000075%	—	—	—	—	05 Sep 2024	04 Sep 2024 - 04 Sep 2024
Christopher M. Crain	MD, General Counsel & Secretary, Co-Owner Show All	Derivative Exercise and Sale (Sale)	-1K	-0.001877%	—	—	$155.29 - $155.29	-$155.29K	03 Sep 2024	03 Sep 2024 - 03 Sep 2024
Gillian Beth Zucker	Independent Director Show All	Automatic Disposition (Sale)	-200	-0.000376%	-2.78%	7K	$152.49 - $152.49	-$30.5K	20 Aug 2024	20 Aug 2024 - 20 Aug 2024
Paul Eric Siegert	Co-Chairman & Global Co-Head of Financial Restructuring, Director Show All	Derivative Exercise and Sale (Sale)	-675	-0.00127%	—	—	—	—	20 Aug 2024	19 Aug 2024 - 19 Aug 2024
Scott Lee Beiser	President, Co-Chairman & Director, Co-Owner Show All	Derivative Exercise and Sale (Sale)	-8.32K	-0.015657%	—	—	$151.89 - $151.89	-$1.26M	16 Aug 2024	16 Aug 2024 - 16 Aug 2024
Irwin N. Gold
David A. Preiser
Christopher M. Crain
Irwin N. Gold
David A. Preiser
Christopher M. Crain
Christopher M. Crain
J. Lindsey Alley
J. Lindsey Alley
Irwin N. Gold
Irwin N. Gold
Scott Lee Beiser
Scott Lee Beiser
Scott Joseph Adelson
Scott Joseph Adelson
Todd John Carter
Todd John Carter
David A. Preiser
David A. Preiser
J. Lindsey Alley
J. Lindsey Alley
Christopher M. Crain
Christopher M. Crain
Irwin N. Gold
Irwin N. Gold